# XFOR (X4 Pharmaceuticals, Inc.) - SEC EDGAR Financial Statements

> X4 Pharmaceuticals, Inc. reported $9.90M in revenue and a net loss of $80.52M for the trailing twelve months ended September 30, 2026 (up 75.0% year over year), with a 68.8% gross margin and a -812.0% operating margin.

- Canonical: https://convexityos.com/fundamentals/XFOR
- Markdown: https://convexityos.com/fundamentals/XFOR.md
- SEC CIK: 0001501697
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:39 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001501697&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $9.90M | +75.0% YoY |
| Operating Income | TTM | -$80.39M | -812.0% margin |
| Net Income | TTM | -$80.52M | -813.3% net margin |
| Diluted EPS | TTM | -$0.64 | Split-adjusted |
| Free Cash Flow | TTM | -$85.62M | -864.8% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $185.8M | Total debt: $75.19M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $6.50M | $2.60M | $0 | $0 | $0 | $3.00M | $0 | $0 | -- | -- |
| Cost of Revenue | $5.76M | $797K | $0 | $0 | -- | -- | -- | -- | -- | -- |
| **Gross Profit** | $743K | $1.80M | $0 | $0 | -- | -- | -- | -- | -- | -- |
| Research & Development | $72.72M | $81.64M | $72.02M | $61.06M | $50.65M | $41.93M | $30.16M | $20.35M | $17.07M | $17.83M |
| Total Operating Expenses | -- | -- | $107.5M | $87.57M | $85.11M | $62.87M | $51.70M | $29.09M | $22.25M | $24.35M |
| **Operating Income** | -$86.88M | -$36.40M | -$107.5M | -$87.57M | -$85.11M | -$59.87M | -$51.70M | -$29.09M | -$22.25M | -$24.35M |
| **EBITDA** | -$85.61M | -$35.60M | -$107.1M | -$87.06M | -$84.61M | -$59.52M | -$51.60M | -$28.98M | -$22.18M | -$24.06M |
| Interest Income | $4.58M | $5.77M | $4.58M | $219K | $10K | $273K | $1.20M | $236K | $64K | -- |
| Interest Expense | $8.88M | $8.77M | $5.78M | $3.99M | $3.64M | $2.69M | $2.15M | $720K | $490K | $2.52M |
| Income Before Tax | -$79.16M | -$37.14M | -$101.1M | -$93.84M | -$88.68M | -$61.98M | -$52.81M | -$33.28M | -$21.99M | -$22.98M |
| Income Tax Expense | $41K | $310K | $78K | $28K | $17K | $148K | $0 | $0 | -- | -- |
| **Net Income** | -$79.20M | -$37.45M | -$101.2M | -$93.87M | -$88.70M | -$62.13M | -$52.81M | -$33.28M | -$21.99M | -$22.98M |
| Basic EPS | -$1.87 | -$5.59 | -$17.07 | -$45.65 | -$119.82 | -$92.79 | -$139.04 | -$2,376.88 | -$1,639.04 | -$8,068.66 |
| **Diluted EPS** | -$1.87 | -$5.59 | -$17.07 | -$45.65 | -$119.82 | -$92.79 | -$139.04 | -$2,376.88 | -$1,639.04 | -$8,068.66 |
| Basic Shares Outstanding | 42.3M | 6.7M | 5.9M | 2.1M | 857.4K | 668.6K | 383.9K | 15.3K | 15.3K | 2.9K |
| Diluted Shares Outstanding | 42.3M | 6.7M | 5.9M | 2.1M | 857.4K | 668.6K | 383.9K | 15.3K | 15.3K | 2.9K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $2.80M | $2.40M | $2.50M | $2.20M | $1.60M | $1.70M | $900K | $1.43M |
| Cost of Revenue | $513K | $1.62M | $598K | $364K | $351K | $326K | $4.72M | $302K |
| **Gross Profit** | $2.29M | $783K | $1.90M | $1.84M | $1.25M | $1.37M | -$3.82M | $1.13M |
| Research & Development | $13.34M | $15.08M | $15.45M | $18.52M | $17.34M | $18.35M | $18.51M | $21.70M |
| **Operating Income** | -$19.99M | -$16.39M | -$20.31M | -$23.70M | -$27.51M | -$26.23M | -$9.44M | -$35.72M |
| **EBITDA** | -$19.66M | -$15.39M | -$20.08M | -$23.48M | -$27.29M | -$25.88M | -$8.97M | -$35.44M |
| Interest Income | $1.82M | $1.98M | $2.10M | $1.99M | $901K | $665K | $1.02M | $1.27M |
| Interest Expense | $2.19M | $2.16M | $2.13M | $2.19M | $2.26M | $2.23M | $2.20M | $2.30M |
| Income Before Tax | -$20.20M | -$16.16M | -$20.24M | -$23.93M | -$29.84M | -$25.70M | $316K | -$39.56M |
| Income Tax Expense | $3.0K | $2.0K | $0 | $0 | -$30K | $37K | $34K | $258K |
| **Net Income** | -$20.20M | -$16.16M | -$20.24M | -$23.93M | -$29.82M | -$25.74M | $282K | -$39.82M |
| Basic EPS | -$0.16 | -$0.13 | -$0.16 | -- | -$0.69 | -$3.47 | $0.04 | -- |
| **Diluted EPS** | -$0.16 | -$0.13 | -$0.16 | -- | -$0.69 | -$3.47 | $0.04 | -- |
| Basic Shares Outstanding | 126.5M | 126.3M | 126.3M | -- | 43.3M | 7.4M | 6.8M | -- |
| Diluted Shares Outstanding | 126.5M | 126.3M | 126.3M | -- | 43.3M | 7.4M | 6.9M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $217.0M | $55.70M | $99.22M | $121.7M | $81.79M | $78.71M | $126.2M | $8.13M | $26.68M |
| **Cash & Short-Term Investments** | $253.0M | $102.1M | $114.2M | $121.7M | $81.79M | $78.71M | $126.2M | $8.13M | $26.68M |
| Accounts Receivable, Net | $573K | $1.07M | $0 | -- | -- | -- | $0 | -- | -- |
| Inventory | -- | $2.82M | $0 | -- | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- | -- | -- | -- | $348K |
| **Total Current Assets** | $261.6M | $112.2M | $122.1M | $128.7M | $87.88M | $83.31M | $129.3M | $9.34M | $79.53M |
| Property, Plant & Equipment, Net | $182K | $776K | $745K | $1.10M | $1.51M | $1.24M | $403K | $241K | $421K |
| Goodwill | $17.35M | $17.35M | $17.35M | $17.35M | $17.35M | $27.11M | $27.11M | $0 | -- |
| Intangible Assets | $9.25M | $10.00M | $0 | -- | -- | -- | -- | -- | -- |
| Other Non-Current Assets | $692K | $2.08M | $1.44M | $1.23M | $1.72M | $3.26M | $1.95M | $364K | $948K |
| **Total Non-Current Assets** | $28.88M | $34.27M | $25.18M | $26.91M | $29.30M | $39.56M | $31.42M | $605K | $1.72M |
| **Total Assets** | $290.5M | $146.4M | $147.3M | $155.6M | $117.2M | $122.9M | $160.7M | $9.94M | $81.25M |
| Accounts Payable | $5.70M | $8.62M | $8.95M | $7.78M | $4.28M | $3.14M | $2.09M | $2.97M | $1.89M |
| Short-Term Debt | -- | -- | $0 | $1.31M | $795K | $0 | $0 | $1.69M | -- |
| Deferred Revenue (Current) | $464K | $0 | -- | -- | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $25.76M | $32.88M | $22.86M | $22.32M | $14.02M | $11.95M | $9.45M | $7.91M | $10.68M |
| Long-Term Debt | $75.00M | $75.00M | $54.57M | $32.30M | $33.14M | $33.18M | $20.00M | $8.31M | -- |
| Deferred Revenue (Non-Current) | $621K | $0 | -- | -- | -- | -- | -- | -- | -- |
| Other Non-Current Liabilities | $525K | $831K | $432K | $173K | $826K | $462K | $16K | $205K | $9.0K |
| **Total Non-Current Liabilities** | $78.41M | $91.42M | $73.30M | $59.21M | $38.74M | $38.12M | $22.03M | $13.71M | $11.87M |
| **Total Liabilities** | $104.2M | $124.3M | $96.16M | $81.53M | $52.76M | $50.07M | $31.48M | $21.62M | $22.55M |
| **Total Debt (incl. Leases)** | $75.99M | $77.66M | $58.28M | $37.10M | $38.99M | $38.45M | $22.82M | $10.00M | -- |
| Common Stock | $91K | $6.0K | $167K | $122K | $28K | $16K | $16K | $0 | $15K |
| Retained Earnings | -$594.6M | -$515.4M | -$477.9M | -$376.7M | -$282.9M | -$194.2M | -$132.0M | -$79.24M | -$92.27M |
| Accumulated Other Comp. Income | -$109K | -$122K | -$119K | -$119K | -$119K | -$119K | -$119K | $0 | $127K |
| **Total Stockholders' Equity** | $186.3M | $22.15M | $51.10M | $74.05M | $64.41M | $72.80M | $129.2M | -$77.09M | -$44.55M |
| Total Equity | $186.3M | $22.15M | $51.10M | $74.05M | $64.41M | $72.80M | $129.2M | -$77.09M | -$44.55M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $185.8M | $195.1M | $216.9M | $217.0M | $69.63M | $39.22M | $40.26M | $55.70M |
| **Cash & Short-Term Investments** | $187.7M | $208.0M | $233.7M | $253.0M | $122.2M | $63.00M | $87.00M | $102.1M |
| Accounts Receivable, Net | $1.47M | $2.05M | $1.11M | $573K | $891K | $1.15M | $509K | $1.07M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | $2.82M |
| **Total Current Assets** | $198.1M | $218.9M | $242.0M | $261.6M | $132.8M | $72.94M | $95.70M | $112.2M |
| Property, Plant & Equipment, Net | $57K | $111K | $146K | $182K | $218K | $254K | $487K | $776K |
| Goodwill | $17.35M | $17.35M | $17.35M | $17.35M | $17.35M | $17.35M | $17.35M | $17.35M |
| Intangible Assets | $12.82M | $13.10M | $9.06M | $9.25M | $9.44M | $9.62M | $9.81M | $10.00M |
| Other Non-Current Assets | $3.19M | $2.99M | $704K | $692K | $1.97M | $2.35M | $3.01M | $2.08M |
| **Total Non-Current Assets** | $33.68M | $34.21M | $28.30M | $28.88M | $30.75M | $32.23M | $34.32M | $34.27M |
| **Total Assets** | $231.8M | $253.1M | $270.3M | $290.5M | $163.6M | $105.2M | $130.0M | $146.4M |
| Accounts Payable | $4.88M | $3.93M | $5.07M | $5.70M | $5.05M | $7.71M | $11.12M | $8.62M |
| Deferred Revenue (Current) | $938K | $842K | $910K | $464K | $592K | $754K | $855K | $0 |
| **Total Current Liabilities** | $14.98M | $19.37M | $23.77M | $25.76M | $23.51M | $22.90M | $25.88M | $32.88M |
| Long-Term Debt | $75.00M | $75.00M | $75.00M | $75.00M | $75.00M | $75.00M | $75.00M | $75.00M |
| Deferred Revenue (Non-Current) | $391K | $592K | $117K | $621K | $789K | $827K | $955K | $0 |
| Other Non-Current Liabilities | $522K | $523K | $526K | $525K | $525K | $535K | $567K | $831K |
| **Total Non-Current Liabilities** | $77.95M | $78.24M | $78.06M | $78.41M | $78.43M | $78.30M | $81.19M | $91.42M |
| **Total Liabilities** | $92.93M | $97.61M | $101.8M | $104.2M | $101.9M | $101.2M | $107.1M | $124.3M |
| **Total Debt (incl. Leases)** | $75.19M | $75.47M | $75.73M | $75.99M | $76.30M | $77.18M | $77.41M | $77.66M |
| Common Stock | $101K | $96K | $94K | $91K | $25K | $8.0K | $6.0K | $6.0K |
| Retained Earnings | -$651.1M | -$631.0M | -$614.8M | -$594.6M | -$570.6M | -$540.8M | -$515.1M | -$515.4M |
| Accumulated Other Comp. Income | $0 | -$123K | -$122K | -$109K | -$118K | -$138K | -$128K | -$122K |
| **Total Stockholders' Equity** | $138.9M | $155.5M | $168.4M | $186.3M | $61.62M | $3.97M | $22.94M | $22.15M |
| Total Equity | $138.9M | $155.5M | $168.4M | $186.3M | $61.62M | $3.97M | $22.94M | $22.15M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$79.20M | -$37.45M | -$101.2M | -$93.87M | -$88.70M | -$62.13M | -$52.81M | -$33.28M | -$21.99M | -$22.98M |
| Depreciation & Amortization | $1.28M | $796K | $419K | $513K | $499K | $351K | $103K | $103K | $71K | $285K |
| Stock-Based Compensation | $4.30M | $8.20M | $8.69M | $5.20M | $6.18M | $5.43M | $2.05M | $759K | $492K | $644K |
| Change in Receivables | $497K | -$1.07M | $0 | $0 | -- | -- | -- | -- | -- | -- |
| Change in Inventory | -$1.66M | -$2.82M | $0 | $0 | -- | -- | -- | -- | -- | -- |
| Change in Payables | -$2.98M | -$286K | $1.23M | $3.42M | $1.17M | $1.03M | -$2.75M | $1.31M | -$1.17M | $1.26M |
| **Operating Cash Flow** | -$85.62M | -$130.9M | -$96.51M | -$77.10M | -$70.91M | -$58.82M | -$48.05M | -$25.42M | -$21.31M | -$21.64M |
| Capital Expenditure | $0 | -$326K | -$60K | -$103K | -$615K | -$1.36M | -$174K | $0 | -$378K | -$73K |
| **Free Cash Flow** | -$85.62M | -$131.2M | -$96.57M | -$77.20M | -$71.52M | -$60.18M | -$48.23M | -$25.42M | -$21.69M | -$21.71M |
| Purchases of Investments | -$63.39M | -$57.13M | -$16.82M | $0 | $0 | -- | -- | -- | -- | -- |
| **Investing Cash Flow** | $8.15M | $66.99M | -$14.88M | -$103K | -$615K | -$1.36M | $27.23M | $0 | -$378K | -$73K |
| Common Stock Issued | $238.5M | $0 | $60.00M | -- | -- | -- | -- | -- | -- | -- |
| Share Repurchases | -- | -- | $0 | $0 | -$2.00M | $0 | $0 | -- | -- | -- |
| **Financing Cash Flow** | $238.6M | $20.29M | $88.52M | $117.2M | $74.25M | $12.39M | $140.7M | $6.87M | $33.42M | $18.15M |
| **Net Change in Cash** | $161.4M | -$43.77M | -$22.78M | $39.92M | $2.41M | -$47.38M | $119.6M | -$18.55M | $11.73M | -$3.67M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$20.20M | -$16.16M | -$20.24M | -$23.93M | -$29.82M | -$25.74M | $282K | -$39.82M |
| Depreciation & Amortization | $331K | $997K | $223K | $223K | $223K | $355K | $476K | $273K |
| Stock-Based Compensation | $3.50M | $3.09M | $2.41M | $2.27M | $760K | $748K | $519K | $2.22M |
| Change in Receivables | $578K | -$934K | -$541K | $318K | $254K | -$636K | $561K | -$1.07M |
| Change in Inventory | -$5.0K | -$865K | -$158K | -$399K | -$910K | -$81K | -$272K | -$372K |
| Change in Payables | $949K | -$1.14M | -$624K | $642K | -$2.65M | -$3.44M | $2.48M | $78K |
| **Operating Cash Flow** | -$20.19M | -$20.79M | -$19.60M | -$15.53M | -$27.82M | -$29.90M | -$12.37M | -$32.99M |
| Capital Expenditure | -- | -- | -- | $0 | $0 | $0 | $0 | -$41K |
| **Free Cash Flow** | -- | -- | -- | -$15.53M | -$27.82M | -$29.90M | -$12.37M | -$33.04M |
| Purchases of Investments | $0 | $0 | $0 | -$1.90M | -$44.53M | -$5.07M | -$11.89M | -$22.78M |
| **Investing Cash Flow** | $11.00M | -$1.00M | $19.25M | $16.85M | -$28.67M | $23.11M | -$3.14M | -$8.62M |
| **Financing Cash Flow** | -$112K | $75K | $2.0K | $146.1M | $86.91M | $5.63M | $0 | $135K |
| **Net Change in Cash** | -$9.29M | -$21.72M | -$365K | $147.4M | $30.41M | -$1.02M | -$15.43M | -$41.73M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 11.4% | 69.3% | -- | -- | -- | -- | -- | -- | -- | -- |
| **Operating Margin** | -1336.7% | -1400.0% | -- | -- | -- | -1995.8% | -- | -- | -- | -- |
| **Net Profit Margin** | -1218.4% | -1440.4% | -- | -- | -- | -2071.0% | -- | -- | -- | -- |
| Return on Equity (ROE) | -42.5% | -169.1% | -198.0% | -126.8% | -137.7% | -85.3% | -40.9% | -- | -- | -- |
| Return on Assets (ROA) | -27.3% | -25.6% | -68.7% | -60.3% | -75.7% | -50.6% | -32.9% | -334.7% | -27.1% | -- |
| Current Ratio | 10.16x | 3.41x | 5.34x | 5.76x | 6.27x | 6.97x | 13.68x | 1.18x | 7.45x | -- |
| Quick Ratio | 9.84x | 3.33x | 5.34x | 5.45x | 5.83x | 6.59x | 13.36x | 1.03x | 2.50x | -- |
| Debt to Equity | 0.41x | 3.51x | 1.14x | 0.50x | 0.61x | 0.53x | 0.18x | -- | -- | -- |
| **Revenue Growth (YoY)** | +150.0% | -- | -- | -- | -100.0% | -- | -- | -- | -- | -- |
| Gross Profit Growth (YoY) | -58.8% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | -96.6% | -- | -- | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 68.8% | 66.3% | 79.5% | 10.0% | -1.1% | -21.3% | -59.5% | 68.8% |
| **Operating Margin** | -812.0% | -1010.4% | -1221.8% | -1357.5% | -1755.4% | -2305.0% | -247.5% | -1423.6% |
| **Net Profit Margin** | -813.3% | -1036.1% | -1246.5% | -1237.5% | -1687.9% | -2219.8% | 422.3% | -1464.6% |
| Return on Equity (ROE) | -58.0% | -58.0% | -59.2% | -42.5% | -154.3% | -2568.0% | 63.6% | -169.1% |
| Return on Assets (ROA) | -34.7% | -35.6% | -36.9% | -27.3% | -58.1% | -97.0% | 11.2% | -25.6% |
| Current Ratio | 13.22x | 11.30x | 10.18x | 10.16x | 5.65x | 3.19x | 3.70x | 3.41x |
| Quick Ratio | 12.62x | 10.85x | 9.88x | 9.84x | 5.24x | 2.80x | 3.38x | 3.33x |
| Debt to Equity | 0.54x | 0.49x | 0.45x | 0.41x | 1.24x | 19.44x | 3.37x | 3.51x |
| **Revenue Growth (YoY)** | +75.0% | +41.2% | +177.8% | +53.4% | +185.7% | +202.0% | -- | -- |
| Gross Profit Growth (YoY) | +83.1% | -43.0% | -- | +62.2% | +275.1% | +365.8% | -- | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -136.9% | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -7277.7% | -- | -- | -128.3% | -- | -- |
| EPS Growth (YoY) | -- | -- | -500.0% | -- | -- | -125.5% | -- | -- |

## Related Companies

[RBNE (Robin Energy Ltd.)](https://convexityos.com/fundamentals/RBNE), [WOK (WORK Medical Technology Group LTD)](https://convexityos.com/fundamentals/WOK), [ASST (Strive, Inc.)](https://convexityos.com/fundamentals/ASST), [AMBO (Ambow Education Holding Ltd.)](https://convexityos.com/fundamentals/AMBO), [SERV (Serve Robotics Inc.)](https://convexityos.com/fundamentals/SERV), [NTCL (NetClass Technology Inc)](https://convexityos.com/fundamentals/NTCL), [NMTC (NeuroOne Medical Technologies Corporation)](https://convexityos.com/fundamentals/NMTC), [NBY (Stablecoin Development Corporation)](https://convexityos.com/fundamentals/NBY)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
